Por favor, use este identificador para citar o enlazar este ítem: http://cicy.repositorioinstitucional.mx/jspui/handle/1003/2674
Citroflavonoids as promising agents for drug discovery in diabetes and hypertension: A systematic review of experimental studies
ROLFFY RUBEN ORTIZ ANDRADE
JESUS ALFREDO ARAUJO LEON
Juan Carlos Sanchez_Salgado
AMANDA SANCHEZ_RECILLAS
Priscila Vazquez-Garcia
EMANUEL HERNANDEZ NUÑEZ
Acceso Abierto
Atribución-NoComercial-SinDerivadas
https://doi.org/10.3390/molecules27227933
BIOCHEMICAL PARAMETERS
BLOOD MARKERS
GENE EXPRESSION
HESPERIDIN
NARINGENIN
PROTEIN CONTENT
Flavonoids are naturally occurring compounds widely distributed in the Citrus genus. These natural compounds have many health benefits, mainly for metabolic and cardiovascular diseases. In fact, some these compounds are components of drug products with approved indications for peripheral vascular insufficiency and hemorrhoids. However, information on pharmacological effects of these compounds remains disperse and there is scarce comprehensive analysis of whole data and evidence. These kinds of evidence analyses could be necessary in drug design and the development of novel and innovate drug products in diabetes and hypertension. We aimed to systematically search for evidence on the efficacy of citroflavonoids in diabetes and hypertension in in vivo models. We searched four literature databases based on a PICO strategy. After database curation, twenty-nine articles were retrieved to analyze experimental data. There was high heterogeneity in both outcomes and methodology. Naringenin and hesperetin derivates were the most studied citroflavonoids in both experimental models. More investigation is still needed to determine its potential for drug design and development. © 2022 by the authors.
2022
Artículo
Molecules 2022, 27, 7933.https://doi.org/10.3390/molecules27227933
Inglés
Ortiz-Andrade, R.; Araujo León, J.A.; Sánchez-Salgado, J.C.; Sánchez-Recillas, A.; Vazquez-Garcia, P.; Hernández-Núñez, E. Citroflavonoids as Promising Agents for Drug Discovery in Diabetes and Hypertension: A Systematic Review of Experimental Studies. Molecules 2022, 27, 7933.https://doi.org/10.3390/molecules27227933
BIOLOGÍA MOLECULAR
Versión publicada
publishedVersion - Versión publicada
Aparece en las colecciones: Artículos de Investigación Arbitrados

Cargar archivos:


Fichero Tamaño Formato  
2022_Rolffy_Ortiz.pdf1.05 MBAdobe PDFVisualizar/Abrir